**News Article: Intuitive Surgical Reports Strong Revenue Growth, Driven by Procedure Volume and System Sales**
Intuitive Surgical Inc. (ISRG) has announced its financial results, showcasing a significant increase in revenue and profitability. The company reported total revenue of $10.1 billion for the year ended December 31, 2025, a 21% increase compared to $8.4 billion in the previous year. This growth was primarily fueled by a surge in procedure volumes and higher system sales. Net income attributable to Intuitive Surgical, Inc. reached $2.86 billion, translating to $7.87 per diluted share, compared to $2.32 billion, or $6.42 per diluted share, in the prior year.
The company's financial performance was underpinned by robust operational developments. Approximately 3.15 million da Vinci procedures were performed in 2025, marking an 18% increase from the 2.68 million procedures in 2024. Instruments and accessories revenue, a key indicator of procedure volume, rose by 19% to $6.02 billion. System sales also experienced substantial growth, increasing by 26% to $2.47 billion, driven by the placement of 1,721 da Vinci surgical systems, a 13% increase year-over-year. The company's installed base of da Vinci systems reached 11,106, a 12% expansion from the previous year.
Strategic initiatives and product launches contributed to the company's success. The fifth-generation da Vinci 5 surgical system saw significant adoption, with 870 units placed in 2025, compared to 362 in 2024. The Ion endoluminal system also experienced growth, with approximately 144,100 procedures performed, a 51% increase from the previous year. However, Ion system placements decreased by 28% to 195 units, reflecting a shift in customer focus from capacity expansion to utilization of existing systems. The company's gross profit margin stood at 66.0%, a slight decrease from 67.5% in the previous year, attributed to factors such as new tariffs and higher costs associated with the da Vinci 5 system.
Looking ahead, Intuitive Surgical anticipates continued growth, albeit with potential challenges. The company expects to make substantial investments in research and development to expand its product offerings. However, it acknowledges potential headwinds from macroeconomic conditions, including inflationary pressures, supply chain constraints, and geopolitical instability. The company also faces increasing competition in the robotic-assisted surgical system industry, particularly in China. Despite these challenges, Intuitive Surgical remains optimistic about its long-term growth prospects, driven by its commitment to innovation and its focus on delivering value to patients, physicians, and hospitals.
About INTUITIVE SURGICAL INC
Intuitive Surgical designs and manufactures robotic-assisted surgical systems, primarily the da Vinci platform, and diagnostic endoluminal tools like Ion. Its products enhance minimally invasive procedures across multiple specialties, improving clinical outcomes, patient experience, and operational efficiency. The company serves hospitals and healthcare providers worldwide, offering integrated hardware, instruments, accessories, training, and support services to expand access to high-quality, less invasive care.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.